Skip to main content
Top
Published in: Diabetology International 3/2015

01-09-2015 | Original Article

Effect of the new diagnostic criteria for gestational diabetes mellitus among Japanese women

Authors: Etsuko Nobumoto, Hisashi Masuyama, Yuji Hiramatsu, Takashi Sugiyama, Hideto Kusaka, Nagayasu Toyoda

Published in: Diabetology International | Issue 3/2015

Login to get access

Abstract

Background

The new diagnostic criteria for gestational diabetes mellitus (GDM), proposed by the International Association of Diabetes and Pregnancy Study Groups in 2010, were recently accepted in Japan. Therefore, the frequency of GDM is four times higher than previously recorded. This means that GDM has become a more clinically important disease. This study aimed to assess how the number of patients with GDM as well as its complications have changed after adoption of the new criteria.

Methods

A total of 3,610 pregnant women in the Japan Assessment of GDM Screening Trial and Okayama University Hospital were included. We analyzed the prevalence of GDM and its complications using the old and new criteria.

Results

The prevalence of perinatal outcomes was increased by adopting the new criteria. There were many important perinatal complications in the additional new GDM criteria; therefore, patients with mild GDM, such as one-point disorder patients, should have careful interventions. Admission to the neonatal intensive care unit was significantly increased (p = 0.01) according to the new GDM criteria because the old criteria were stricter than the new ones. GDM patients with obesity (BMI ≥ 25 kg/m2) had a high frequency of perinatal complications that could require active intervention and strict follow-up.

Conclusions

Because the new GDM criteria greatly affect perinatal complications, intervention for GDM starting at an early stage and strict follow-up (especially GDM with obesity) are important for reducing complications as well as the incidence of diabetes and metabolic syndrome in the mother and child.
Literature
1.
go back to reference Shin J, Lee J, Kim H, Choi Y, Cho J, Yoon K. Prevention of diabetes: a strategic approach for individual patients. Diabetes Metab Res Rev. 2012;28(Suppl 2):79–84.CrossRefPubMed Shin J, Lee J, Kim H, Choi Y, Cho J, Yoon K. Prevention of diabetes: a strategic approach for individual patients. Diabetes Metab Res Rev. 2012;28(Suppl 2):79–84.CrossRefPubMed
2.
go back to reference Getahun D, Nath C, Ananth C, Chavez M, Smulian J. Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol. 2008;525:e1–5. Getahun D, Nath C, Ananth C, Chavez M, Smulian J. Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol. 2008;525:e1–5.
3.
go back to reference International Association of Diabetes and Pregnancy Study Groups. Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676–82.CrossRef International Association of Diabetes and Pregnancy Study Groups. Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676–82.CrossRef
4.
go back to reference The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002.CrossRef The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002.CrossRef
5.
go back to reference Morikawa M, Yamada T, Yamada T, Akaishi R, Nishida R, Cho K, et al. Change in the number of patients after the adoption of IADPSG criteria for hyperglycemia during pregnancy in Japanese women. Diabetes Res Clin Pract. 2010;90:339–42.CrossRefPubMed Morikawa M, Yamada T, Yamada T, Akaishi R, Nishida R, Cho K, et al. Change in the number of patients after the adoption of IADPSG criteria for hyperglycemia during pregnancy in Japanese women. Diabetes Res Clin Pract. 2010;90:339–42.CrossRefPubMed
6.
go back to reference Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352:2477–86.CrossRefPubMed Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352:2477–86.CrossRefPubMed
7.
go back to reference Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361:1339–48.PubMedCentralCrossRefPubMed Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361:1339–48.PubMedCentralCrossRefPubMed
8.
go back to reference Gillman MW, Oakey H, Baghurst PA, Volkmer RE, Robinson JS, Crowther CA. Effect of treatment of gestational diabetes mellitus on obesity in the next generation. Diabetes Care. 2010;33:964–8.PubMedCentralCrossRefPubMed Gillman MW, Oakey H, Baghurst PA, Volkmer RE, Robinson JS, Crowther CA. Effect of treatment of gestational diabetes mellitus on obesity in the next generation. Diabetes Care. 2010;33:964–8.PubMedCentralCrossRefPubMed
9.
go back to reference Langer O, Berkus MD, Huff RW, Samueloff A. Shoulder dystocia: should the fetus weighing greater than or equal to 4000 grams be delivered by cesarean section? Am J Obstet Gynecol. 1991;165:831–7.CrossRefPubMed Langer O, Berkus MD, Huff RW, Samueloff A. Shoulder dystocia: should the fetus weighing greater than or equal to 4000 grams be delivered by cesarean section? Am J Obstet Gynecol. 1991;165:831–7.CrossRefPubMed
10.
go back to reference Veciana MD, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, et al. Postrandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med. 1995;333:1237–41.CrossRefPubMed Veciana MD, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, et al. Postrandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med. 1995;333:1237–41.CrossRefPubMed
11.
go back to reference Riskin-Mashiah S, Damti A, Younes G, Auslender R. First trimester fasting hyperglycemia as a predictor for the development of gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol. 2010;152:163–7.CrossRefPubMed Riskin-Mashiah S, Damti A, Younes G, Auslender R. First trimester fasting hyperglycemia as a predictor for the development of gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol. 2010;152:163–7.CrossRefPubMed
12.
go back to reference Maegawa Y, Sugiyama T, Kusaka H, Mitao M, Toyoda N. Screening tests for gestational diabetes in Japan in the 1st and 2nd trimester of pregnancy. Diabetes Res Clin Pract. 2003;62:47–53.CrossRefPubMed Maegawa Y, Sugiyama T, Kusaka H, Mitao M, Toyoda N. Screening tests for gestational diabetes in Japan in the 1st and 2nd trimester of pregnancy. Diabetes Res Clin Pract. 2003;62:47–53.CrossRefPubMed
13.
go back to reference Nilofer AR, Raju VS, Dakshayini BR, Zaki SA. Screening in high risk group of gestational diabetes mellitus with its maternal and fetal outcomes. Indian J. Endocrinol Metab. 2012;16(Suppl 1):s74–8.PubMedCentralPubMed Nilofer AR, Raju VS, Dakshayini BR, Zaki SA. Screening in high risk group of gestational diabetes mellitus with its maternal and fetal outcomes. Indian J. Endocrinol Metab. 2012;16(Suppl 1):s74–8.PubMedCentralPubMed
14.
go back to reference Gluckman PD, Hanson MA. Living with the past: Evolution, development, and patterns of disease. Science. 2004;305:1733–6.CrossRefPubMed Gluckman PD, Hanson MA. Living with the past: Evolution, development, and patterns of disease. Science. 2004;305:1733–6.CrossRefPubMed
15.
go back to reference Kim SY, England L, Sappenfield W, Wilson HG, Bish CL, Salihu HM. Racial/ethnic differences in the percentage of gestational diabetes mellitus cases attributable to overweight and obesity, Florida, 2004–2007. Prev Chronic Dis. 2012;9:e88.PubMedCentralPubMed Kim SY, England L, Sappenfield W, Wilson HG, Bish CL, Salihu HM. Racial/ethnic differences in the percentage of gestational diabetes mellitus cases attributable to overweight and obesity, Florida, 2004–2007. Prev Chronic Dis. 2012;9:e88.PubMedCentralPubMed
16.
go back to reference Takimoto H, Sugiyama T, Fukuoka H, Kato N, Yoshiike N. Maternal weight gain ranges for optimal fetal growth in Japanese women. Gynecol Obstet. 2006;92:272–8. Takimoto H, Sugiyama T, Fukuoka H, Kato N, Yoshiike N. Maternal weight gain ranges for optimal fetal growth in Japanese women. Gynecol Obstet. 2006;92:272–8.
17.
go back to reference Rogozinska E, Jolly K, Glinkowski S, Roseboom T, Tomlinson JW, Kunz R, et al. Effects of interventions in pregnancy on maternal weight and obstetric outcomes meta-analysis of randomized evidence. BMJ. 2012;344:e2088.PubMedCentralCrossRefPubMed Rogozinska E, Jolly K, Glinkowski S, Roseboom T, Tomlinson JW, Kunz R, et al. Effects of interventions in pregnancy on maternal weight and obstetric outcomes meta-analysis of randomized evidence. BMJ. 2012;344:e2088.PubMedCentralCrossRefPubMed
18.
19.
go back to reference Cheng YW, Chung JH, Block IK, Inturrisi M, Shafer S, Caughey AB. Gestational weight gain and gestational diabetes mellitus perinatal outcomes. Obstet Gynecol. 2008;112:1015–22.CrossRefPubMed Cheng YW, Chung JH, Block IK, Inturrisi M, Shafer S, Caughey AB. Gestational weight gain and gestational diabetes mellitus perinatal outcomes. Obstet Gynecol. 2008;112:1015–22.CrossRefPubMed
20.
go back to reference Petiit DJ, Baird HR, Aleck KA, Bennett PH, Knowler WC. Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. N Engl J Med. 1983;308:242–5.CrossRef Petiit DJ, Baird HR, Aleck KA, Bennett PH, Knowler WC. Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. N Engl J Med. 1983;308:242–5.CrossRef
21.
22.
go back to reference Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373:1773–9.CrossRefPubMed Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373:1773–9.CrossRefPubMed
23.
go back to reference Gunderson EP, Quesenberry CP, Jacobs DR, Feng J, Lewis CE, Sidney S. Longitudinal study of pregnancy cardiometabolic risk factors and subsequent risk of gestational diabetes mellitus. Am J Epidemiol. 2010;172:1131–43.PubMedCentralCrossRefPubMed Gunderson EP, Quesenberry CP, Jacobs DR, Feng J, Lewis CE, Sidney S. Longitudinal study of pregnancy cardiometabolic risk factors and subsequent risk of gestational diabetes mellitus. Am J Epidemiol. 2010;172:1131–43.PubMedCentralCrossRefPubMed
24.
go back to reference Vargas LG, Addison SS, Nistala R, Kurukulasuriya D, Sowers JR. Gestational diabetes and the offspring: Implications in the development of the cardiorenal metabolic syndrome in offspring. Cardiorenal Med. 2012;2:134–42.CrossRef Vargas LG, Addison SS, Nistala R, Kurukulasuriya D, Sowers JR. Gestational diabetes and the offspring: Implications in the development of the cardiorenal metabolic syndrome in offspring. Cardiorenal Med. 2012;2:134–42.CrossRef
Metadata
Title
Effect of the new diagnostic criteria for gestational diabetes mellitus among Japanese women
Authors
Etsuko Nobumoto
Hisashi Masuyama
Yuji Hiramatsu
Takashi Sugiyama
Hideto Kusaka
Nagayasu Toyoda
Publication date
01-09-2015
Publisher
Springer Japan
Published in
Diabetology International / Issue 3/2015
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-014-0193-8

Other articles of this Issue 3/2015

Diabetology International 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine